Related Experiment Video
Updated: Apr 12, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
[miR-328 Inhibits K562 Cell Proliferation by Up-regulation of C/EBPα Expression]
Jin-Xia Cao1, Feng Wen1, Hao Wang2
1Department of Hematology, The First Hospital, Nanhua University, Hengyang 421000, Hunan Province, China.
Objective:
Our research was aim to investigate the effect of microRNA-328 (miR-328) on proliferation of chronic myeloid leukemia(CML) cell K562 and the mediated effect of C/EBPα.
Methods:
The eukaryotic expression vectors of miR-328 targeting gene and suppressor gene (hsa-miR-328 and hsa-miR-328-inhibitor) were constructed, and transfected into K562 cells respectively. The mRNA expression levels of miR-328 and C/EBP α were detected by real-time fluorescence quantitative RT-PCR; C/EBP α protein expression was detected by Western blot; CCK-8 was used to estimate the cell viability.
Results:
The recombinant genes of hsa-miR-328 and hsa-miR-328-inhibitor were successfully constructed and transfected into K562 cells. Fluorescent cells were observed after 24 h, and the visible fluorescence cells were gradually increased after 48 h or 72 h, the miR-328 showed no effect on the mRNA expression of C/EBPα detected by RT-PCR. Meanwhile, miR-328 showed recovering effect on C/EBPα translation and inhibition of K562 cells proliferation.
Conclusion:
miR-328 has been successfully constructed and transfected into K562 cells, miR-328 inhibits the proliferation of K562 cells by up-regulation of C/EBPα.
Insights
MicroRNA-328 (miR-328) effectively inhibits chronic myeloid leukemia (CML) cell proliferation. This occurs through the upregulation of C/EBPα, demonstrating miR-328
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Context:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by uncontrolled proliferation of myeloid cells.
- K562 cell line is a widely used model for studying CML.
- MicroRNAs play crucial roles in gene regulation and have emerged as potential therapeutic targets in cancer.
Purpose:
- To investigate the effect of microRNA-328 (miR-328) on the proliferation of K562 CML cells.
- To elucidate the role of CCAAT/enhancer-binding protein alpha (C/EBPα) in mediating the effects of miR-328.
Summary:
- Successfully constructed and transfected eukaryotic expression vectors for miR-328 and its inhibitor into K562 cells.
- miR-328 demonstrated no significant effect on C/EBPα mRNA levels but recovered C/EBPα translation.
- miR-328 inhibited K562 cell proliferation, indicating an inhibitory role in CML progression.
Impact:
- Establishes miR-328 as a potential inhibitor of K562 cell proliferation.
- Highlights the role of miR-328 in regulating C/EBPα translation.
- Suggests miR-328 as a potential therapeutic agent for chronic myeloid leukemia.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
MicroRNAs
Abnormal Proliferation
Mitogens and the Cell Cycle

